ニュース

Novo Nordisk is betting on a CEO shake-up to regain its weight loss drug edge over Eli Lilly
Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Zacks Investment Research on MSN2 日
Novo Nordisk Shares Dip 3% on Sudden CEO Transition Announcement
Novo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...
Medical Marketing & Media2 日
Novo Nordisk CEO to step down in the face of rising market challenges
Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...
Pharmaceutical Technology2 日
Novo Nordisk’s CEO to step down as weight loss market share plummets
Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...
The Week2 日
Asian shares slide US futures and dollar drop after Wall Street's winning week
Asian shares fell Monday and US futures and the dollar weakened after Moody's Ratings downgraded the sovereign credit rating for the United States because of its failure to stem a rising tide of debt.